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WELCOME TO DEAN WARWICK
It is with great pride that the J ournal staff announces that Dr. 0 . H . Warwick has
consented to be the Honorary Staff Advisor to the J ou rnal.
As you wi ll read in the informative, yet humorous biog raphy by Dr. Manning, Dean
Warwick has been associated with the Chemotherapy of Cancer as a N uffield Fellow in
England, as th e first M ed ical D irector of the N ational Cancer Institute, and as Senior
Physician at the Ontario Cancer Institute, and the adj oining Princess Ma.rgaret Hospital
in Toronto.
It is with great pleasure th at the Journal dedicates th is issue to ou.r newly appointed
Dean, Dr. 0 . H . W arwick .

DR. 0. H. WARWICK

MESSAGE FROM THE DEAN
To my predecessor in office, Dr. Collip, I express my t hanks, and those of my
colleagues, for the very active and progressive school which he has left to our care.
Medical education, research and practice are finely inter-woven in a pattern
which we know to be constantly chang ing. My functi on as Dean wi ll be primarily
to coordinate within the un iversity fami ly the efforts of our teachers an d research
workers. The ultimate purpose of the efforts of all of us is to produce good doctors
and to advance medical knowledge.
I w.:>uld like the undergraduates to real ize that the Dean t ook a medical course
similar to yours twenty-five years ago and that he is willing at all times to share
the intervening years of experience with any student who finds himself in difficulty
or trouble. You will find him an easy-going fellow with a sense of humor which
will cease to exist only when the conduct and behavior of students fall below
standards which befit doctors and the profession of medicine.
He is contrary enough also to believe that being the 13th Dean of this Fa.culty
of Medicine is a good omen, not a bad one. He looks forward to his years with you
and with those who follow you.
NOVEMBER,
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Dr. 0. H. Warwick
Dean of Medicine
DR. GEORGE W. MANNING,
M.A., M.D., PhD., F.R.C.P.(C).

ated with another Rhodes scholar from
Australia, our Professor of Biochemistry,
Dr. Roger Rossiter. Those were the days
before the War and I am sure that many
of them were spent both at study and
indulging in a good old "spot-of-tea" in
their "digs" or the local Oxonian "tea
houses" following their day of exposure to
the lectures and laboratory sessions provided by the Dons of Oxford. Dr. Warwick
returned to McGill followi ng the completion of his work at Oxford and continued
a brilliant academic career, graduating in
1940 with the M.D .C.M. as the Wood
Gold Medalist. Immediately after graduation, he became a junior intern at the
Royal Victoria Hospital in Montreal,
where his first patient was the late Maude
Abbot. Perhaps many of you do not reDr. Warwick was born in 1915 at St.
member Dr. Maude Abbot. This little old
John, N .B. Following graduation from St.
lady of moderate proportions was, howJohn High School, he proceeded to Mount
ever, the founder of Pediatric Cardiology
Allison University, N .S., completing his
as we know it to-day. Her study and classiB.A. degree in 1935. He then attended fication of congenital heart disease in 1,000
McGill, where in 1936, as an undergradcases was without doubt the stimulus that
uate medical student in his first year, he
led to the further work of Taussig and
was awarded the Rhodes scholarship. The
Blalock and the great host of research and
Rhodes, as we are well aware, is given not
investigation that has led to our present
only for outstanding scholastic achieveday approach to the diagnosis and treatment, but also for general proficiency, inment of congenital heart disease. She was
clud!ng sports which in his case included
truly a forerunner of Pediatric Cardiology
basketball and hockey (both of which renot only in Canada but in the entire world
quire a good deal of active mobility which
.- a "St. John crying in the wilderness" as
he continues to demonstrate to a considerMcMurrich so aptly applied to Leonardo
able degree).
da Vinci. This was our Dean's first patient
During the next two years, he completed· whom he had the privilege of treating in
hi$ B.A. and M.A. degrees in physiQlogy . her last illness, an.d. I may venture to say
in the Honors School at Oxford. Across _h_e has had no_·more·. p~~ant, app~eciati~e
the · tabie in ·the physiology iaboratory at ·and, perhaps, "important patient, · ·pa-rticuOxford, he met and became closely associ- larly to cardiology; to serve'since that time.

For the past fourteen years, Western has
had the privilege of having as Dean of
Medicine one of Canada's outstanding
scientists. Dr. Collip has brought recognition to <this school far beyond that which
most of us realize. We are now entering a
new era which in the years .to come will
see an even greater medical centre here at
our University of Western Ontario. Those
responsible for the long term planni ng of
our University and Medical School have
been successful in obtaining a successor for
Dr. Collip, who, from his repuation as a
scientist, clinician and administrator, will
certainly continue the tradition of this
school and its aims, to provide an even
greater educational and research centre for
Canada.
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Following this brief internship at the
Royal Victoria Hospital in Montreal, Dr,
Warwick, along with practically all the
other young physicians of those rather
gloomy years, whose services to the armed
forces were urgently required, enlisted in
the R.C.A.F.
My first contact with him was in 1941
when he was posted to No. 2 R.C.A.F.
clinical investigation unit at Regina. First
impressions are interesting to reflect upon.
Here was an active, "continually moving"
young man, with a sense of humor, ability
of expression, wit, knowledge and keen
observation. "Hal" as we came to know
him, never could or did keep still and certainly the saying that no one ever stands
still, he either moves backward or forward ,
applied here. It was obvious from the beginning that the direction was forward .
Following a short tour of duty at Regina
Dr. Warwick proceeded to the "Y" depot
at Halifax where he was responsible, with
Dr. C. B. Stewart, now Dean of Medicine
at Halifax, for the high altitude selections
program. In 1943, he proceeded overseas where he served the Canadian Bomber
Group. At the end of hostilities, he returned to McGill where the late Professor J. C.
Meakins offered him the post of Resident
in Medicine at the Royal Victoria Hospital,
for which the competition at the time, with
so many return ing for training, was most
acute. This year was a most successful and
satisfactory year both for Hal and the
Royal Victoria Hospital, following which
he was selected as McGill's choice for one
of the first four Nuffield Fellowships offered to Canada. During the year 1946-47,
he obtained the M.R.C.P. degree (on the
first attempt) and worked at both the
Royal Cancer Hospital and Brompton
Chest Hospital, where he was one of the
first to investigate the value of nitrogenmustard in the treatment of bronchogenic
carcinoma. During this year, he assisted in
the investigation of and application of
other forms of chemotherapy in the cancer
field, which of course provided an excel-

lent background for the specialty with
which he later associated himself.

This was a year of austerity in England
with food and fuel rationing so severe that
the Warwicks used to bed down at night
in "ski suits" . Their third child, Peter, was
born in Old London at "Withering
Heights", during that fueless and foodless
year. An egg was indeed a rarity, milk
rationed so severely that one was forced
to drink beer (unpasteurized). The weekly
"joint" was obtained by using all the
points one could muster and was sort of a
newspaper
wrapped surprise package
which had to be obtained from the one
butcher on your list. In spite of the difficulties he managed to enjoy what I am
sure was a most valuable year; for the
Nuffield Foundation had been most cooperative (except for the stipend) in obtaining the various posts, courses, etc. in
which he was interested. Since it was
obvious that the amount of the Fellowship
would fall considerably short of supporting him and his family for the year, it was
necessary to either borrow or by some
devious manner acquire additional funds.
H al hit upon an ingenious scheme. It started with a desire of a wealthy Scottish
friend for an American Buick car (at any
cost). Hal bought the Buick, delivered in
packing case at the port of London, at a
cost of approximately 2,000.00. (He, of
course, had to learn to drive in the meantime!) Having possessed the car for a very
short period, he was then free to sell it
and this was done to the Scot for approximately $4,000.00, leaving a good profit
and a good deal of lumber from the packing case, which also proved most useful for
sundry purposes. "Project Buick" had been
a most satisfactory venture not only for
"car Salesman for a day" Warwick, but
also for me, for I was able to borrow a
large number of five pound notes (at no
interest) allowing me also to get back to
Canada. (This, by the way, was a legitimate way to get money out of England,
difficult at that time!)
f2~

---~. AVarunc·R.~---------------------------------------

Returning to Canada after a most successful year in London, and one of which,
I am sure, he will have many fond memories, Hal entered private practice in
Montreal as an internist attached to the
teaching staff of the Royal Victoria Hospital. After one year, he was invited to
become the first Medical Director of the
National Cancer Institute. He ·then moved
to Toronto to take up this position, and,
as well, a staff appointment at the Toronto
General Hospital. In 1955, with t he creation of the Ontario Cancer Institute and
Princess Margaret Hospital in Toronto, he
left the National Cancer Institute to become senior physician at this institution,
and Assistant Professor of Medicine at the
University of Toronto, which positions he
occupied until coming •to Western in July
1961. His particular research interests have
been in the fields of chemotherapy of malignant disease and in .the various metabolic disorders associated with this group of
diseases, and he has to his credit a large
number of research publications in this
field. For three years, he represented the
British Commonwealth in the International
Union against cancer.

Dr. Warwick's esteem of the University
of Western Ontario is apparent from the
fact that his oldest daughter, Wendy, had
registered at U .W .O. sometime before he
was invited to accept the position of Dean
of Medicine at Western.

•
-~

Our new Dean has many accomplishments, one of the most important being
the acqu isition, a "few " years ago, of a
most charming wife. Their four childrenWendy, Glynn, Peter and Vicky, being the
offspring of remarkable parents will, I am
sure, continue the Warwick traditions of
active progress coupled with humility and
the ability to make every situation pleasantly successful
There is no doubt that we can look forward to a most productive and pleasant
administration of the med ical faculty during the coming years. As a personal friend
of Dean Warwick, I am sure that he will
excuse this rather informal introduction,
and , knowing him as I do, I can assure
you that there should be no hesitation
whatsoever in seeking his advice whenever
you have problems with which he may be
able to help you.

...
...
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Recent Trends
In Cancer Dlness
With the conquest of infectious diseases,
and the increasing age of our population,
cancer has risen in importance as a cause of
illness and death. Since 1937, it has been
second only .to heart disease as the cause
of death on this continent. In addition to
this relative increase in cancer mortality,
most observers feel that there is an absolute increase in the cancer death rate.
Many factors seem to be related to cancer illness. These include age, race, place
of residence, stage of illness at time of
diagnosis, and sex. In the last twenty years,
the cancer mortality rate for men has risen
significanly, while that for women has
fallen . The maio site responsible for this
incre:lSed mortality in the male population
is the respiratory system and particularly
the bronchi. There have been lesser but
still significant increases in male mortality
due to cancer of the urinary and genital
organs, leukemias, and lymphatic and hematopoietic system malignancies. The male
mortality rate from cancer of the buccal
cavity and stomach has decreased significantly. No significant change has occurred
in the male mortality rate from cancer of
the intestines including the rectum .
In females, the main cause for the decline in the cancer mortality rate has been
due .to the falling mortality from cancer
of the body of the uterus. This is particularly striking since the rate from carcinoma
of cervix has risen while the overall rate
for the uterus has fallen. In females, too,
there has been an increased cancer mortality rate from leukemias, and lymphatic and
hematopoietic system malignancies, but a
NOVEMBER, 1961

decrease in the rate from cancer of the
stomach. No increase has occurred in the
mortality rate from cancer of the rectum,
but the rate from cancer of the intestines
has fallen . T here has also been no significant change in the female mortality rate
from cancer of the buccal cavity, respiratory system, urinary organs and breast.
In all of the sites mentioned, the mortality rates have been, and continue to be
higher in males than females except in
cancer of the intestines, not including the
rectum. A further, interesting relationship
between sex and cancer illness is seen when
the cancer incidence rates are considered.
Male cancer incidence rates for non-reproductive organs are higher at all ages.
However, the cancer incidence rates for
reproductive organs, including breast, are
greater for females until age 70.
Besides its relative increase as a cause of
morbidity and mortality, cancer has come
to enjoy a far more important place in the
medical and lay mind . It has become the
subject of a major part of t oday's medical
speculation and research in the search for
its etiology and means of treatment.
The term "cancer" comes from a Latin
term for a crab. Paul of Aegina claims that
it is so-called because " it adheres to any
parts which it seizes upon in an obstinate
manner like a crab" (Skinner). The authors of the various articles in this journal
have attempted to show how modern medical methods have succeeded in loosening
the crab's feet. J,t remains for the doctors
of the future to remove the menace of the
crab's body.
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Vincaleukoblastine:
A New Chemotherapeutic
Agent

•

...

BARRY WRIGHT, '62

INTRODUCilON
The discovery and isolation of Vincaleukoblastine is an example of how a
chance observation can lead to the development of a valuable clinical adjunct in
the trea ment of disease.

THE EARLY WORK

betes mellitus. When the aqueous extract
was injected intraperitoneally into rats, the
In 1949, when the investigation that led effect soon became obvious. In most cases,
to the isolation of Vincaleukoblastine death followed in 5-7 days, and autopsy
(VLB, or Vinblastine Sulfate) was launch- showed multiple ascesses resulting from a
ed, Dr. R. L. Noble and his colleagues at septicemia. Dr. R. G . E. Murray of the
the Collip Medical Research Laboratory Department of Bacteriology consistently
were interested in the extracts of plants reported the presence of Pseudomonas in
reputed by folklore and historical hearsay the exudates. By coincidence, the same
to have medicinal properties. The chemo- findings were obtained from other laboratherapy of cancer was not under consider- tory animals receiving large doses of coration when they heard of a tea made from tisone. It was concluded, then, that death
the leaves of a West Indian shrub, the in both experiments followed the suppreswhite-flowered periwinkle, or Vinca rosea sion of some mechanism of defense against
Linn, which was said to be useful in <the infection. Further studies showed that the
treatment of diabetes mellitus. This plant periwinkle extraot caused a granulocytohad been used throughout the world for penia and depression of the bone marrow.
the treatment of a variety of conditions, The investigation was continued rather
and as early as 1910 had been described as sporadically, as time allowed, until 1955,
having healing properties. In Europe, it when an intensive chemical study was
was used for the suppression of lactation; organized. The first step was to compare
in the British West Indies, for the treat- the activity of various species of the shrub
ment of diabetic ulcers; and in the Phili- and the different parts of the individual
pines, as an oral hypoglycemic agent_ It plant. The active principle was located in
was therefore decided that an investigation the root, stem and leaves, the latter being
of the effects of the extract on blood sugar most active, but the seeds were inactive.
should be undertaken, and a supply of the Cultivation of the plant as an annual was
leaves was obtained from Black River, undertaken near London, Ontario, but the
yield of the active substance was found to
Jamaica.
be only one-quarter of that of the perenIt was disappointing to find that an nial which grew wild in the West Indies.
aqueous extract of the leaves, when admin- Careful assessment of each step of the
istered orally, had no effect on the blood fractionation process, and bioassay of each
sugar of either normal or diabetic rats or fraction obtained, based on the peripheral
rabbits. Doctors J. C. Rathbun and H. A. leukopenia and marrow depression, showMcAlpine of this University even visited ed that a number of fractions with differJamaica briefly to investigate the claims ent properties and degrees of activity
for the effectiveness of the plant in dia- could be isolated.
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STANDARDIZATION

A wide variety of tumors were treated
with VLB, but those responding best included hemopoietic tumors (monocytic and
myeloblastic leukemias, leuko-lymphosarcoma, Hodgkin's Disease) and choriorcarcinoma, of which two cases showed
some regression of pulmonary metastases.
One case of adenocarcinoma of the colon
appeared to be improvedt but_\~ors of
nerve tissue, vascular tissue, smooth muscle
and connective tissue were unresponsive.
Although the most effective dose schedule
has yet to be determined, the drug was
usually given in a daily dose of 0.15
mg./kg. into the tubing of an intravenous
infusion of saline or glucose, for 3 or 4
consecutive days, and repeated if necessary
when the toxic effects subsided. In a recent
study conducted by a group headed by Dr.
0 . H . Warwick, ten doses of 0.02 mg./kg.
were given at hourly or half-hourly intervals, and repeated in one week if the leukocyte count exceeded 3,000 per cu. mm.
Treatment was continued as long as 8
months with relatively few side effects.

Best results were obtained by extraction
with an ethanol-acetic acid solvent. A number of fractions were then identified in the
extract, the most potent being Fraction 9.
The active substance in this fraction, which
was then named Vincaleukoblastine, was
found to be an alkaloid with the empirical
formula, c .GH 5 OuN •. It was purified and
obtained as the crystalline sulfate for biological studies, but because this produced
ariable results on intraperitoneal injection,
the free base in propylene glycol became
the standard preparation. Normal rats
showed a severe granulocytopenia lasting
3-5 days, followed by a rapid recovery.
Weight loss was constant, but there was no
effect on the gut, or on the regenerating
liver in partially hepatectomized rats. The
effect of stibestrol on the rat uterus was
antagonized by VLB. It was found that an
amount of the drug equal to 3-4 times a
single lethal dose could be given over a
ten day period. Mice bearing standard
experimental tumors (leukemias, Ehrlich
There have been numerous manifestaascites tumor, mammary tumor) survived tions of toxic side effects, but none was
significa ntly longer when given VLB soon serious enough to warrant discontinuation
after the injection of the tumor cells. Sur- of treatment. VLB is locally destructive,
vival was prolonged also by the pre-treat- causing thrombophlebitis when injected
ment of the innoculurn, but not of the directly into a vein. The systemic reactions
mice themselves. In fact, the pre-treated recorded by various authors include:
mammary tumor did not grow at all, but
1. Anorexia, nausea, vomiting
when the animals were given untreated
tumor cells, later, they died after the
2. Weight loss
average interval. VLB had a striking effect
in clearing the peripheral blood of circu3. Dizziness
lating myeloid leukemic cells, although
survival time was not increased. The most
4. Depression and behavioral changes
effective dose schedule was a 24-hour treat5. Some suppression of deep tendon rement period, rather than a long series of
flexes
daily injections.
6. Paresthesia of fingers and feet
CLINICAL STUDIES
Because in animal studies VLB showed
some promise of effectiveness as an antileukemic agent, a number of investigators
undertook clinical studies on selected cases.
NOVEMBER,
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7. Bilateral pain and tenderness of the
parotid glands with mouth dryness
8. Constipation and urinary retention
9. Decrease in hemoglobin
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-Vincaleukoblastine-----------------10. Inhibition of erythropoiesis
11. Occasionally a slight depression of
platelet count

REFERENCES
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SUMMARY
VLB (Vinblastine), an alkaloid from the
plant Vinca rosea, is a ne~ chemotherapeutic
agent of limited usefulness in the treatment of malignant and allied diseases. It
has only a slight and temporary effect on a
broad spectrum of solid tumors, but is of
definite clinical value in the management
of choriocarcinoma and Hodgkin's D isease.
With regard to the latter ~o diseases, it
has been pointed out that the use of VLB
should be reserved until after conventional
therapy has been given.
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Perfusion for the Chemotherapy
of Cancer
R. SHEPHERD, '63

INTRODUCilON
The results of 'using chemicals for the treatment of cancer are generally disappointing because drugs now available damage normal as well as malignant
tissues. Recently, the tumor region has been isolated and perfused through an
extra-co rporeal circulation in an attempt to increase the dose of the drug to the
tumor, and decrease its effect on the rest of the body.

AGENTS
Alkylating agents and antimetabolites
are the commonest of many types of drugs
used clinically. Alkylating agents produce
a cytolgic effect similar to that of radiotherapy, and are at times referred t o as
" radiomimetic". Nitrogen mustard, the
foremost of these is taken up by the tissues
within minutes, whereas Thio-TEPA remains acti e for several hours and is not so
useful for perfusion. Antimetabolites such
as the folic acid analogue, Methotrexate,
and the purine analogue, mercaptopurine,
are incorporated into tissues very slowly
and are therefore not used in perfusion.

TECHNIQUE

't -

...

Drugs have been injected locally into the
artery supplying the tumor region to deliver a larger dose to the growth. A rapidly
inactivated drug, and partial venous occlusion
may be used to enhance the localization of
activity of the compound. A larger dose
has been obtained by isolating the blood
supply of the tumor region by sphygmomanometer cuffs around limbs, or by clamps
applied to the vessels. An artery and a vein
in the isolated region are <then cannulated
and connected to an extra-corporeal circulation containing a pump and oxygenator.
The fluid can then be recirculated through
the tumor region and the amount which
will leak into the general circulation will
depend on the euent of the collateral vessels which have not been occluded. The
amount of leakage, which is further deNOVEMBER, 1961

creased by maintaining the perfusion pressure at a level lower than that of the
general circulation, can be found by the
inclusion of labelled red blood cells or
RISA in the perfusate. The use of any
long-acting compounds in perfusion requires that they be re!Jloved from the
circuit before normal circulation in the
region is re-established. The procedure can
then be used for the treatment of locally
advanced lesions, or as an adjunct to surgery or radiotherapy in an attempt to decrease the incidence of cancer recurrences.

EXPERIMENTAL WORK

Animal experiments were required to
deter:mine ·the most suitable time period
and pressure for perfusion, and the maximum tolerable dose. Duration of activity
of the chemotherapeutic agent was determined by bioassay studies. Working with
the hind limb Qf the dog, and using the
femoral vessels to perfuse, Creech found
that a dose of 2 mgm./kg.of PAM(phenylalanine mustard) produced no ill effects.
This is equivalent to the safe oral dose, or
twice the systemic dose. Since the hind
limb of .t he dog represents only 1/20 the
total body weight, the concentration achieved by this method far exceeds that made
possible by earlier techniqu~. Attempts to
further increase the effect on the rumor
have involved the use of a perfusate
having a very high 0 2 tension, perfusion
with drug combinations, and the use of
radiotherapy along with perfusion.

135

--Chemotherapy of Ca11cer - - - - - - - - - - - - - - CLINICAL APPLICATION
This procedure has been used in patients
with malignant disease judged refractory
to conservative treatment such as radiotherapy. The method of isolating the
region varies from site to site. In the limbs,
a tourniquet can be applied and the femoral
vessels cannulated in the leg, while in the
arm and forearm the axillary artery and vein
may be used . Cannulation of the third part
of the subclavian artery will permit perfusion of the axillary lymph nodes, which
is important if these nodes are involved.
Perfusion of the pelvic region requires
occlusion of the aorta and inferior vena
cava below their renal branches, and cannulation of these vessels above their bifucation. Tourniquets applied to the lower
extremities then complete isolation of the
extra-corporeal circuit. Perfusion of the
lung is a major procedure and requires two
extra-corporeal circuits. The first cicuit is
used to perfuse the lung by a left atrium
to pump-oxygenator to pulmonary artery
circuit, while the second circuit maintains
the systemic circulation by a venae cavae to
pump to oxygenator to femoral artery circuit. Mixing of the systemic and perfusing
circuits is prevented in this case by caval
occlusion and the isolation is very efficient.
In the extremities, mixing is slight, and
dosage is limited by the reaction of local
tissues to the agent. In most other sites
where tourniquets are ineffective and leak-

age is high, dosage is limited by the danger
of systemic effects.
Perfusion has been carried out on locally
advanced lesions involving the limbs,
pelvis, lungs, breast, brain, transverse
colon, and scapula, with improvement in
about 1/ 3 of cases. Complete regression of
a tumor has never occurred. The results of
perfusion to prevent recu rrence after surgical excision of the primary tumor are not
available.

SUMMARY
A tumor may now be treated with a
large dose of a drug, using an extra-corporeal circulation. The commonly used drugs
are nitrogen mustard, Thio-TEPA and
PAM. Best results are obtained when the
lesions in limbs are perfused because a
much larger dose can be delivered . On e
third of cases selected for this form of
therapy show improvement.

REFERENCES
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Supervoltage Therapy
TERRY CULLEN, '63

INfRODUCfiON
In the past decade, cobalt-60 beam therapy and supervoltage x-ray therapy have
been made availabl e for the treatment of cancer. Both of these offer ma.rked
improvement over conventional ray therapy and both ca n be included under the
titl e of upervoltage Therapy.

DEFINITION
Supervoltage Therapy is the term used
in therapeutic radiology when referring to
treatment using very high energy, short
wavelength radiations. The energy of the
radiations ranges from one million to one
hundred million electron volts, (1-100
MeV) , but only between one to thirty MeV
is commonly used today. The two types of
energy beams by far t he most commonly
employed are gamma-rays and supervoltage
x-rays . At the present time, the term Supervoltage Therapy applies most properly in the
clinical, but not experimental sense, to high
energy gamma and x-ray therapy.

PARTICLES AND RAYS USED
IN THERAPY
There are many different particles and
rays which are used in varying amounts
for therapy, and, for the sake of completeness, these are listed below. They include
the two this paper shall discuss, namely,
x-rays and gamma-rays.
Charged particles
electrons or beta particles
protons
alpha particles
Uncharged particles
neutrons
Electromagnetic rays
x-rays
gamma-rays

X-RAYS AND GAMMA-RAYS
In order to appreciate the term Supervoltage therapy, an understanding of rays
NOVEMBER,

1961

in general is necessary, as well as some
knowledge of both radiosensitivity and
radiocurability. Below is an outline of
these.

Gamma-ray Production
Gamma rays are spontaneously emitted
from the nuclei of disintegrating radioactive isotopes, usually along with alpha
or beta particles or both. Alpha particles
(posi ti ve helium nuclei ), and beta particles
(negative electrons) , are both charged and
have mass, but neither is used to any great
degree in medicine at present. From radioactive isotopes, usually only gamma-rays
are allowed ,to reach living tissue.
Examples of radioactive isotopes are
Radium (Ra 226 ) and Cobalt (Co 60 ), where
the number indicates isotopic weight.
RAdium
Radium is a naturally occurring element
which has a half-life of 1,620 years and
which produces a whole series of disintegration products, finally becoming lead.
Alpha and beta particles and gamma-rays
are emitted during the disintegration process. Radium has been replaced in the last
decade by Cobalt-60 which has many
advantages over Radium .
Disadvantage of RAdium as a beam source
1. I·t is hard to prepare and difficult to
handle.
2. There is a possibility of leakage, causing
contamination.
3. It is expensive.
4. It is not available in great quantity.
Advantage of Radium
It has a long half-life and hence is useful
for a long period of time.

--Supervoltage T h e r a p y - - - - - - - - - - - - - - - Cobalt

Cobalt-60 is an artificially made isotope
which emits primarily very high energy
gamma rays and which has a half-life of
5.3 years. The two gamma-rays emitted
have energies in the supervoltage range,
these being 1.17 and 1.33 MeV. Cobalt-60
rays are an excellent alternative to high
energy x-rays produced by supervoltage
x-ray machines.

X-Ray Production
X-rays a e produced by x-ray tubes only.
Such a tube is an evacuated device containing an anode and filamentous cathode,
and arranged such that when voltage is
applied, a stream of electrons is accelerated
from the cathode •to the target anode where
the kinetic energy of the electrons is transformed into heat and x-rays. Actually, a
whole spectrum of x-rays is emitted, all the
wavelengths of which are small as compared
with light or radio waves.
Quality of X-rays

It is possible, by using a filter, to absorb
the longer wavelengths and allow only the
shorter ones through. Further, by increasing the voltage, more short waves will be
produced. Thus, voltage and filtrati on .determine the quality of the x-ray beam.
Short waves have greater energy than longer waves and hence penetrate more deeply
into matter. It shouJ,d be pointed out that
x-ray machine input voltage, in the conventional low range, is expressed in kilovolts
(kV) where a kilovolt equals one thousand
volts, and in tbe supervoltage range, in
megavolts (MV) where a megavolt equals
one million volts.
Output energy from both x-ray and
gamma-ray sources is expressed in MeV.
The average quality of x-rays generated at
one MV will be less than one MeV. Thus
cobalt-60, at an average output energy of
1.25 MeV equals the output of a 3 million
volt (3MV) x-ray tube.

Specific Methods of X-ray Production
for Therapeutic Purposes
1. Tramformer Rectifier
This is useful for voltages up to one
million but is used mostly in the region of
250kV.
2. Electrostatic systems

The Van de Graaf type of generator
exemplifies this and can excite x-ray tubes
up to two million volts.
3. A ccelerators

For energies in the supervoltage range
above two million volts, the direct use of
high voltage is not practical and therefore
device have been developed to utilize the
same voltage repeatedly to build up the
energy of the electrons. The two main types
of accelerators are:
1. Linear
2. Cyclic; Betatron, Synchrotron.
In .these, the particles are accelerated along
a straight line or cyclic path. The linear
accelerator has an energy range up to 5
MeV, while the cyclic accelerator can deliver up to 50 MeV.

j

Summary
Originally, voltages used in x-ray ·therapy were in the 100-400kV range. In 1936,
a large one million volt unit was established in London, England, and in the past
decade or so, high speed accelerators have
pushed output energy well over 1 MeV
and truly into the supervoltage field .
Nature of X-Rays and Gamma-Rays

Both x-rays and gamma-rays are pa~t of
the electromagnetic spectrum of wavelengths, and both are found at the extreme
short wave part of the spectrum. X-ray
and gamma-ray beams are streams of
energy packets or quanta of energy which are
called photons. Photons are weightless and
chargeless energy packets: the energy they
carry is measured in electron volts.
'4
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The Interaction of Rays With Tissue
When ionizing radiation impinges upon
tissue, energy is extracted by the tissue for
certain interaction processes between it and
the radiation beam. The amount of energy
per gram of tissue can be measured or calculated, and is expressed in rads. The rad
is the unit of x- or gamma-ray dosage that
is used in rad iotherapy. The relationship
between energy abs.orbed and tissue response is not completely understood at present due to a lack of knowledge about living
protoplasm itself.
It is known that cells in mitosis and
immature cells are quite sensitive to irradiation, more so than other cells. The
effects of irradiation may be outlined :
Temporary effect
The major effect is suppression of mitosis. This causes cessation of growth, and ,
with increasing ly greater doses, the duration of the mitosis-free period and hence
growth-free period increases.
Permanent effect
The major effect is to damage the mitotic mechanism. The amount of injury to the
sensitive chromosomes depends on the
dose; when high enough, the nuclei become
large and hyperchromatic, chromatin tends
to be dumped and nucleoli become prominent. Bizarre and giant nuclei may appear
in considerable numbers.
It has been argued in the past that because of the similarity of these cells to the
anaplastic cells of neoplasms, malignancy
was increased after irradiation and that
radiation was therefore stimulating. It is
firmly established, however, that radiation
produces ·~ellular injury, and, that while
phenomena may take place that have the
appearanc•: of proliferation or stimulation,
the 'cell itself is always deleteriously
affected .

RADIOSENSITIVI1Y
AND RADIOCURABILITY
Radiosensitivity
Any tissue or tumor can be destroyed if
enough radiation is applied to it. In the
NOVEMBER,
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body, however, the magnitude of dose is
limited by the tolerance of the normal
tissue included in the irradiated volume.
So we might say that tumors which are
eradicated with the maximal or less than
maximal permissible dose are radiosensitive, while those not eradicated with the
maximal permissible dose are radioresistant, where the maximal permissible dose
is determined by normal tissue tolerance to
irradiation.
In the body, the various normal tissues
te~d to differ in their relative sensitivity
to irradiation. For example, lymphoid tissue is the most sensitive and nervous tissue the most resistant. In general, the
radiosensitivity of neoplasms tends to follow that of the tissue from which the
tumor is derived. Hence, lymphosarcoma
and lymphatic leukemia are very sensitive
to irradiation , while gliomas are relatively
resistant.
Many factors affect sensitivity. Two
notable ones are:
1. Cell of origin
As stated above, when a normal cell becomes malignant, its radiosensitivity will
be in the same order as that of its normal
parent.

2. State of cell
Cells in mitosis are more sensitive than
resting cells.
Obviously, in cancer therapy, one must
find that dosage which will give the optimum result. How much radiation can or
should be given to eradicate the tumor at
the risk of destroying some normal tissue?
With low doses, the risk of recurrence is
g reat and the danger of injuring the tumor
bed small, while with bigger doses, the
danger of injury is great and the risk of
recurrence small.

Radiocurability
This term is not synonymous with radiosensitivity but is affected by radiosensitivity as well as by tumor type, infiltrative
and metastatic extent of the tumor, site of
the tumor, character of the tumor bed and
time-dose-volume relationships.
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--Supervoltage T h e r a p y - - - - - - - - - - - - - - - For example, with Hodgkin's lymphosarcoma, radiosensitivity is high, but radiocurability is low due to the metastatic
capabilities of the tumor. On the other
hand, carcinoma of the oral part of the
tongue, if it has not metastasized or infiltrated, is radiocurable because the tongue
has a good vascular bed and is quite
accessible, but the tumor itself is relatively
radioresistant and requires high doses.

SUPERVOLTAGE THERAPY
Sires where applicable
It is not wise to attempt a statistical
evaluation of supervoltage therapy at the
present time due to the variance of opinion
from various centers. However, certain
organs and reg ions have been found to
respond much better with Supervoltage
Therapy than with conventional, low voltage therapy. Below is a partial list of
certain organs and regions in which supervoltage therapy has been tried and in
which a measure of success has been
attained.

Bladder
Cervix
Esophagus
Lung
Rectum
Thyroid
Middle ear
Orbit
Oral cavity
Advantages of Supervoltage Therapy
There are four main advantages of supervoltage therapy over conventional low
voltage therapy:
1. Skin Sparing Effect

With a 250kV machine, maximum ionization occurs within the skin and produces
severe skin reactions. With supervoltage
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radiations, maximum ionization occurs beneath the skin and the patient experiences
much milder superficial reactions. Helping
to produce this effect is the fact that there
is much less back scatter with high than
with low energy radiations.
Because of the decrease in severity of
reactions, more patients are able to finish
their therapy, and, since the last few
hundred rads may determine the result of
therapy, it can be appreciated why lessening skin reactions is so important.
2. Greater penetration

As wavelengths become shorter with increasing voltage, the depth dose increases
and so deep tumors anywhere in the body
can be given a rational dose.
3. Bo11e Sparing Effect
With low energy rays, about ten times
as much radiation is absorbed by bone as
by soft tissue. With high energy rays, bone
absorption is markedly decreased . Therefore there is less chance of precipitating a
pathological fracture after prolonged treatment. Further, tumors on the far side of a
bone will receive adequate treatment with
high energy rays which will penetrate the
bone without being markedly absorbed.
4. Smaller dose to normal tiss11es
Due to greater penetration of the high
energy beams, fewer fields need be used
in therapy with a resultant drop in dosage
received by normal tissue. Further, less
scatter in both lateral and backward directions results in confinement of the beam
to a smaller field , and this too decreases
normal tissue irradiation.
Disadvantages of Supervoltage Therapy
These have been overcome, for the most
part, by modern techniques.
1. Supervoltage equipment is initially
quite expensive.
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2. With supervoltage, devices are needed to hold thick lead shielding. With low
voltage, lead sheets can be placed on the
patient.
3. With 200kV, the exit dose is low and
need not be g iven the attention of a supervoltage beam exit dose.
4. Above 5MeV, bone absorption again
becomes greater than that of soft tissue.
Cobalt-60 vs. Supervoltage X-ray
Differences between cobalt-60 beam
therapy and supervoltage x-ray are quite
minor and not important clinically. Both
do the same job.

CONCLUSION

r-..
.

t

all of which are dedicated to the eradication of that terrible phenomenon known
as cancer.
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Modern interest in the association of
thrombophlebitis and cancer was revived
by Sproul in 1938. This study demonstrated multiple venous thromboses in 31 % of
cases of carcinoma of the body and tail of
pancreas.
The present authors reviewed 1400 cases
with diagnosis of thrombophlebitis or venous thrombosis, and found 81 to have
associated cancer. In these cases of neoplasm, the thrombophlebitis tended to be
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recurrent or migratory, and to appear in
multiple extremities. One should probably
note that widespread metastases were
frequent.
In this study, the lungs, female reproductive tract, and the pancreas, in this
order were the most frequent original sites.
However, many other sites were also noted.
In several cases, it took some time before
the malignancy was discovered. Many of
the cases were resistant to anticoagulation.
Why such an association? The authors
offered only comments on the elucidation
of such a mechanism.
Robert Moffat, '62
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Preoperative Radiation

.
M. D. MAYNARD, '62

INTRODUCI'ION
This particular topic is presently the subject of much controversy among surgeons
and therapeutic radiologists. Therefore this paper will present only a few of the
concepts in this controversial field .

ADVANI'AGES AND AIMS OF
PREOPERATIVE RADIATION
1. To reduce the local vitality of the malignancy by marked reduction of its size or
its rate of growth, so that operation can be
carried out with a greater chance of eradication of the disease.

2. To reduce the size of tumors where resection might otherwise be more difficult.
3. If one agrees that there is a possibiiity
of surgical manipulation disseminating
malignant cells via vascular or lymphatic
cba,nnels, and if one further agrees that
radiation prior to surgerr. may devitalize
these cells so that a chance of "take" at
some distant lodgement is decreased , then
preoperative therapy is a valid procedure
(]. W. J. CARPENDER). Kaee backs up
this assumption with figures on Grade 3
Carcinoma of Breast.
4. There is an intact blood supply in most
cases which allows higher doses of irradiation which may be more effec.tive than
postoperative radiation.

·and bleeding at surgery with the acute
radiation reaction, and post-irradiation fibrosis may make operation and wound
healing more difficult in the .later stages
of treatment.

J
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4. Length and expense ~f treatment to the
individual and the hospital.
5. The psychological worry of delay
through radiotherapy on the part of the
patient.

1

CONCLUSIONS
Conclusions cannot be drawn from the
above . lists of advantages and objections;
they can only be made ov r a period of
time as reports and comparisons of the
various methods of treatment are made.
Early results of the combined ::ttack with
preoperative irradiation and appropriate
surgery suggests that this combination of
treatment is a real advancement in the
<treatment of Bronchogenic Carcinoma.
(Bloedorn and Cowley)

,
..
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OBJECfiONS TO COMBINED
PREOPERATIVE RADIATION
THERAPY AND SURGERY
1. The

possibility that metastases will
develop• while therapy is under way during the waiting period.
2. Irradiation effect is not maximal until
two months after treatment.
3. Possible increase in operative and postoperative morbidity due to radiotherapy.
There is a resultant increased vascularity
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Mechanisms of Anemias
ASSOCIATED WITH NEOPLASTIC DISEASE,
With Special Reference To The Leukemias,
I.ymphomas And Multiple Myeloma
WILLIAM BROWN, '63
INTRODUCI'ION
Anemia is commonly associated with neoplastic disease and indeed, the first
indication of an underlying neoplasm may be the signs and symptoms of an ~emi.a .
Although variable in the picture presented, many of the mechanisms operattve m
anemias of non-neoplastic origin may be operative also in anemias associated with
neoplasti c disease.
Special reference will be made to anemias associated with neoplastic disease
having origin in hemopoietic tissue because of the dose relationship, anatomically
and physiolegically, which these neoplasms have to normal blood-forming tissues ..
I propose to discuss the subject under the following headings, well recognizing
the fa ct that a treatment of the subject in this way tends to separate the mechanisms,
where in actual fact, in many patients, multiple mechanisms combine to cause the
anemia.
A. Hemorrhage
B. Increased Hemolysis
C. Relationship to Bone Marrow Metastases
D . Effects of Therapy
1. Ionizing Radiation
2. Chemotherapy
E. Nutritional Factors
Special Reference to:
1. Leukemia
.
2. Neoplastic Conditions chiefly involving the lymph nodes
3. Multiple Myeloma

HEMORRHAGE
Chronic loss of blood as a cause of
anemia in neoplastic disease is most frequently the result of neoplasms involving
the alimentary canal, the genital tract (particularly in females), and the urinary tract.
A sustained loss of blood from an ulcerated neoplasm leaes to a progressive fall
in the hemoglobin level which, until it
falls below 50%, may not be accompanied
by the usual clinical signs of an anemia.
The staining of feces, urine, discharges or
vomitus is, however, often apparent to the
patient.
Such an anemia usually has the following characteristic features:
1. hypochromic and microcytic appear-

ing erythrocytes,
2. a reticulocyte count rarely exceeding

5%,
3. a color index of around 0.6,
NOVEMBER,
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4. normoblastic appearing bone marrow.
Hypochromic microcytic or iron deficiency anemia are applicable terms. The
sources of iron available for the erythropoietic system are dependent on first, a
constant rate of absorption from the gastrointestinal tract, and second, iron storage
in hemopoietic tissues. Here the constant
loss of blood drains the available body reserves of iron, and although it is thought
that in ,t hese anemias there is some increase
in the absorption of iron from the gastrointestinal tract, this latter means of replenishment is inadequate, resulting in the
production : of erythrocytes deficient in
hemoglobin (mean corpusQJlar volume
<BO u.c. and mean corpuscular hemoglobin concentration <30%) . An accompanying stimulation of erythropoiesis is
similarly ineffectual in correcting the
defect.
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--Mechanisms of A n e m i a s - - - - - - - - - - - - - - - - Although iron deficiency can result
from continued bleeding from neoplasms
involving the genito-urinary and respiratory tracts, bleeding from these sites of
sufficient degree to cause anemia ts
unusual.
These anemias are amenable to t reatment with iron but it should be pointed
out that in some instances iron deficiency
anemias may be complicated by other
anemias not amenable .to iron treatment;
for example those due to irradiation,
chemotherapy, hemolysis and myelophthisis. In these complicating anemias, the
mechanisms are different and, therefore,
the therapy of choice will be different.
The hemorrhagic anemias so far d iscussed are those due to hemorrhaging into a
tube, but hemorrhage may also occur into
the neoplasm itself. This type of blood loss
is dinico-pathologically relatively insignificant in human neoplasms but not uncommon in certain experimental tumors arising
in and transplanted to rats. These tumors
may be very large, to t he point of being
heavier than the original weight of .the
animaL Hemorrhage into these tumors can
be quite severe and result in iron deficiency anemia.

1. increased excretion of fecal urobilin-

ogen,
2. increased excretion of urinary urobilinogen,
3. increase in the serum indirect acting
bilirubin.

The hemolytic anemia in patients with
neoplastic disease is most likely due t o a
changed environment in which these cells
live.
A possible clue to the mechanism in
these hemolytic anemias is the detection of
antibodies (agglutinating) in the serum of
these patients. These antibodies have the
ability to act on the host's own erythrocytes. In many instances these same antibodies will react with a donor's red blood
cells, suggesting that either the antigen or
antibody concerned is not host-specific.
There are two classes of hemolytic autoimmune anemias, the idiopathic and symptomatic, the latter being the one that concerns us here. Symptomatic means that it
occurs in association with some other disease, certain neoplasms enumerated below
being one group of these diseases.
Occurrence of Hemolytic anemi a in some
neoplastic diseases :
1. in 15 % of cases of chronic lympho-

cytic leukemia,

INCREASED HEMOLYSIS

2. 7% of cases of Hodgkin's disease,

Hemolytic anemia results whenever a
decreased erythrocyte survival time ( normal 120 days) is not balanced by a sufficient stimulation of erythropoiesis. A
decrease in survival time of the erythrocytes to less than twenty days may be
necessary to produce anemia if the bone
marrow is functioning normaUy because
the bone marrow has the capacity to increase its erythrocyte production six fold .
Thus, unless erythropoiesis is depressed for
some reason, hemolysis and increased
erythropoiesis characterize hemolytic anemia. The increased hemolysis is detectable
by several techniques. Among them are
tests which reveal:

3. commonly in lymphosarcoma
giant follicular lymphosarcoma,
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and

4. rarely in chronic myelocytic leukemia.
Similar antibodies as detected by the
antiglobulin (or Coombs) test are also
found in virus pneumonia and collagen
disease.
Two mechanisms in the formation of
these peculiar antibodies have been suggested:
1. Alteration in the patient's erythrocytes

causes them to act as antigens, which
in turn are responsible for a specific
immune response by the patient.
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2. The original stimulus is non-specific but
causes an outpouring of globulin from
the patient's immune-body forming tissues and this globulin is what is detected
by the Coombs Test.
The means by which these erythrocytes
are actually destroyed in t hese anemias is
open to a g reat deal of question. It has
been suggested that the antibodies coat the
outer surface of the erythrocytes, thus
making them more susceptible to mechanical destruction by the normal trauma
encountered in the circulation, for it has
been demonstrated that erythrocytes so
coated with antibody have an increased
mechanical fragility. Other suggestions include the foll owing:
1.

The presence of antibody at the cell
membrane alters the metabolism at the
membrane surface, leading to spherocytosis and subsequent destruction in
the spleen or circulation. This mechanism is fel t by some authorities to be
unlikel y because of the speed with
which hemolysis has occurred in some
studies.

Wyman also found that by utilizing the
Ashby technique for differential agglutination, the erythrocyte life-span was shortened in excess of the expected, in 15 out
of 16 patients selected from the above 26.
A later study indicated that in the latter
group there was an increased acceleration
in this process as the severity of the disease
progressed. The mechanism of hemolysis
in these hemolytic anemias associated with
carcinomas is unknown .
Another interesting g roup of hemolytic
anemias is seen in patients in whom no
other hemolytic mechanism can be demonstrated or auto-antibodies detected . The
usual features of a hemolytic anemia are
present as well as other findings such as
leukopenia and thrombocytopenia. The
bone marrow is active. This syndrome is
common not only to some of the lymphomas but to many other diseases not discussed in this paper. The cardinal feature
is splenomegaly. The mechanism here is
very poorly understod but it has been suggested that in the affected spleen there is
an increased circulatory stasis causing the
increased erythrocytic destruction.

2. Auto-agglutination and stagnation re-

sulting from the antibody coating causes
cellul ar ischem ia and a release from the
erythrocytes of substances which hasten
erythrocyte destruction. There is no direct evidence to support this contention .
3. The coating by antibody makes the erythrocytes more liable to phagocytosis.
The hemolytic anemias so far discussed
have been in association with the lymphomas and leukem ias but further studies by
W yman have shown that hemolytic anemias may be associated with carcinomas. In
a stud y involvi ng 26 patients, the results
may be briefly summarized as follows :
Moderately increased hemolysis ..... 4%
Slig htly increased hemolysis .
. 54 ~
No significant change .
42 %
In these studies, fecal urobilinogen was
used as the index of hemolytic severity.
NOVEMBER,
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RELATIONSHIP TO BONE MARROW
METASTASES
Myelopthisic anemia is defined as an
anemia associated with space occupying
disorders of the bone marrow and characterized by immature leucocytes and nucleated red blood cells in the peripheral blood.
The anemia here may not be severe.
The commonest cause is metastatic carcinoma from:
1. Breast

2. Prostrate

3. Lung
4. Adrenals
5. Thyroid
Other causes include multiple myeloma
in 5% of cases of that disorder and Hodgkin's Disease.
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-'-Mechanisms of Anemias- - - - - - -- - - - - - - - - The anemia is variable in degree. Commonly, the anemia is normocytic or it may
be macrocytic but the most significant"
factor is the presence of nucleated red
blood cells in the circulation in numbers
quite out of proportion to the anemia.
Normoblasts make up most of these nucleated cells but more primi_tive forms may be
found . Reticulocytes are also increased.
It has been assumed by many writers

that mechanical limitation of hemopoietic
tissue is the operative mechanism in myelophthisic anemias associated with carcinomatous metastases. The total quantity of
red bone marrow is, however, often quite
in excess of the normal amount. Further,
it has been thought by others that hematopoiesis is actually stimulated, and suggestions have been made that there may be
a local nutritional deficieny because of the
demands of the locally g rowing malignant
cells.
Interesting work on the relationshi p of
myelopthisic anemia to bony metastases has
been carried out by Shen and Hamburger.
In a study of approximately 200 cancer
patients, 40 % were found to have a hemo;
globin within normal limits, the other
60 % showing evidence of definite anemia.
Of the 40
with a normal hemoglobin,
34
had evidence of bony metastases as
shown by sternal or iliac as piration. The
60
with an obvious anemia, however,
showed only a 20
incidence of bony
metastases. These findings would natu rally
lead to two conclusions :
1. the finding of an ·anemia is not evi-

dence of bone marrow involvement,
2. the incidence. of anemia is no greater

in the presence of metastases.
These same two workers also drew an
interestjng comparison between the anemia
co-existing with a chronic infection and
that associated with bony metastases. Both
anemias have many characteristics which
are alike morpholog ically. For example:
1. the anemias are usually slight or mod-

erate (hemoglobin over 60
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).

2. they are normochromic or slightly

hypochromic,
3. reticulocyte counts are normal or
slightly increased,
4.

n~rmal

plasma bilirubin,

5. neither is amenable to treatment with
iron or liver.

'

1

In addition, using cobaltous chloride,
Shen and H amburger were able to demonstrate some increase in erythropoietic activity
in both ane~ias, suggesting that, considering their morphologic similarity, their
etiologies are related . This concept is
plausible in view of the fact that many, if
not all, malignancies have some zonal
inflammation and necrosis associated with
them .

l

EFFECfS OF THERAPY

..

Ionizing Radiation
Exposure to ionizing rad iation in the
course of treatment for neoplastic disease
can lead to the production of an anemia
not infrequently superimposed on a p,reexisting anemia. The effects arise from the
action of the electro-magnetic energy
waves. The results depend on two factors :

1

..

1. the kind of radiation

2. the susceptibility of the affected cells.
Hemopoietic tissue is par.ticularly ~us
ceptible to ionizing radiation, particularly
x-rays and gamma-rays which both penetrate the tissue readily.
However, routine radiation therapy uncommonly leads to a permanent or dangerous modification of the blood picture.
Circulating erythrocytes are unaffected except by severe irradiation. In Hodgkin's ·
disease and leukemia, it has been found
that in some cases the number of erythrocytes has actually increased following irradiation, especially if th~ underlying
disease has been favorably treated .
However, if prolonged therapy and
large doses are administered, sometimes
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patients with a lymphoma will show evidence of a marked and persistent depression of erythropoiesis.
Absorption of ionizing radiation by the
cellular molecules leads to a series of chemical changes dependent on the initi~J
ionizing effect of incident electromagnet_lC
waves of given wavelengths on certam
chemical groupings. For example, sulfhydryl group containing enzymes have
been found to be readily inactivated. There
is an inhibition of both RNA and DNA
synthesis which in turn leads to arrests in
the erythropoietic tissues followed by a
subsequent resumption characterized in
some cells by the formation of bizzare
mitotic figures. The synthesis of protein by
the erythropoietic cells is, however, apparently unaffected . Whatever the detailed
chemistry behind the process, the end_ rt~
sult is a suppression of erythrop01es~s
leading to the picture of the aplash_c
anemia. Other factors, of course, contnbute to this suppression, such as the well known effects of irradiation on blood
vessels. It should be pointed out, finally,
in relation to this mechanism, that the
apiastic anemias following irradiation are
usually not too serious and, therefore, as a
rule, dQ not present clinical problems.

Cbemotberapeu~

Drugs

Generally speaking, most of the known
cancer chemotherapeutic drugs depress the
bone marrow in varying degrees depending on the drug and the amount administered. Most of the effects observable in
the bone marrow are attributable to the
fact -that bone marrow cells have a higher
metabolic and mitotic rate than most other
cells in the body and, thus, although the
drug mechanisms of action are the same
for all body cells, they tend to be more
pronounced In a very active tissue such as
bone marrow. Some of these drugs interfere with folic acid metabolism, others are

purine antagonists, still othets are alkylating agents, and, for others, the mechanism of action is as yet not understood .
Whatever their mechanism of action, however the over-all result is the same, namely
a d;pression of the hemop~ietic tissues,
which in turri causes an anemta.

NUTRITIONAL FACfORS
It is well known that in well advanced,
serious metastatic disease the patient frequently presents as generally malnourished
and weakened . This effect is due both to
the direct physical effects of the disease
and psychic influences, the latter not uncommonly suppressing the appetite. ~ancer
cachexia as a single cause of anemJa has
rarely, however, been proven.
Of all the factors essential to normal
erythropoiesis, Vitamin "B 12 and ir~n ~r_e
the only two which have any real stgmftcance etiologically in anemias associated
with neoplastic disease. There are_ .two possibilities which have on occaswn been
thought to be responsible for a Vitami_n
B 12 deficiency, and , therefore, an ~nemta
resembling that of pernicious anemta:

l . the absorption of Vitamin_B12 is inter-

fered with because of the presence of a
gastric carcinoma which upsets both the
normal gastric secretion and the intrinsic factor,

2. storage of Vitamin B12 is interfered with
because of the p~esence iil the liV:er of
massive hepatic metastases. Even when
these metastases are present, it does not,
however, follow that there will be a
Vitamin B12 deficiency.
Iron deficiency has been reported in
cases of total ga.strectomy performed for
treatment of gastric carcinoma.

147

--Mechanisms of Anemias----------------ANEMIAS IN LEUKEMIA
In acute leukemia, hemorrhage is often
a factor but this fact does not account for
the anemia which may be encountered before there is any evidence of bleeding. In
the chronic forms of this disease, bleeding
is rarely a factor to be considered and it is
interesting to note that there is no evidence to support the contention that there
is a deficiency of essential substances
which causes the anemia. Other suggested
mechanisms include:
1. crowding out (myelophthisis) ,

myelocytic anem ia, the life span of the
erythrocytes has been found to be shortened in varying degrees. Thus, it is possible that there is some intrinsic defect in
these cells.
In chronic lymphocytic leukemia, the
life span is normal in most cases but frank
autoimmune hemolysis is a finding not
unusual in these cases. This last finding is
rare in myelocytic and acute leukemic
disease.
Lastly, studies using radioactive Fe59
have shown that in patients with leukemia
erythropoiesis is normal or increased.

2. excessive red blood cell destruction,
3. a lowered red blood cell survival time.

These are considered in turn.
Crowding out is supported by the fact
that as irradiation therapy reduces the
leucocytosis and so leads to a clinical remission, the severity of the associated
anemia also decreases. However, in many
cases, the increased leukopoietic activity
has been found to be co-incident with an
equally increased activity on the part of
erythropoietic tissue, and yet in spite of
this there is still an evident anemia in the
peripheral blood.
There is some evidence to support the
contention that there is an excessive destruction of erythrocytes in leukemia. This
evidence includes the finding of hepatic
hemosiderosis in some cases, while in
others, an increase in the stools and urine
of the products of erythrocyte destruction
has been found.
A third suggestion is that the survival
time of erythrocytes is lowered. In chronic
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NEOPLASMS CHIEFLY INVOLVING

THE LYMPH NODES
1. Giant Follicular Lymphoma

2. Lymphosarcoma
2. Reticulum Cell Sarcoma
4. Hodgkin's Disease
An anemia is often absent in the first
three mentioned, however, it is more common in Hodgkin's disease. This anemia
tends to be normocytic. In Hodgkin's disease the anemia may be very severe, and in
these cases, is likely to be myelophthisic in
character with, however, little associated
lymphadenopathy or splenomegaly. Sometimes in Hodgkin's disease, and less commonly in the first three mentioned, an
acute hemolytic anemia of the symptomatic
1type may be seen, in which case it may be
characterized by maq-ocytosis, spherocytosis,
and even a d~le increase in erythrocyte
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fragility. In these latter types of anemia,
the spleen is also usually affected, showing
splenomegaly. It is also likely that the
anemias associated with these disorders are
related to a shortened life span of the erythrocytes, somehow produced by the primary disorder. Therefore, therapy which is
useful in treating the primary disease is
also useful in d iminishing the severity of
the anemia; iron , liver extracts and Vitamin B12 therapy alone are of no therapeutic value in diminishing the anemia.

t

f

MULTIPLE MYELOMA

Anemia as a symptom may be one of the
reasons for a patient with multiple myeloma presenting himself to his physician .
This anemia is one of the commonest features of the disease and is rarely absent
from at least part of the course of the
disease. The picture of the anemia is
usually characterized by the following
features:

important. The mechanisms of these anemias are also the best understood, at least in
principle if not in detail. Our understanding of mechanisms in hemoly6c anemia,
and in those anemias associated with metastatic neoplastic bone disease is incomplete. It is perhaps significant that most
of the previously discussed mechanisms are
also operable in non-neoplastic disease,
suggesting that the effects of neoplasms
on erythropoiesis are not specific.
Clinically, these anemias can be diagnostically and prognostically quite important.
Others are not very severe nor very important to the diagnosis . Some of these
anemias, particularly those associated with
chemotherapy and irradiation are important to understand because it is not uncommon for such therapy to be discontinued
because of severe hemopoietic depression
which then becomes more serious than the
neoplastic disease itself.
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1
INTRODucriON ·
In r ecent years, there has been considerable study of the hypercalcemia syndrome which occurs in a wide ·variety of diseases. Reports of hypercalcemia have
been made in connection with the following entities: H ypercalcemia of infants ;
Vitamin D intoxication; Milk-alkali syndrome; Hypercalcemia that occu rs occasionally in patients with hyperthyroidism ; Hypercalcemia due to acute osteoporosis
of disuse, especially in young peop le immobilized in plaster or with pol iomyelitis,
also in older people with Pagefs disease; Boeck's sarcoid ; Hyperparathyroidism ;
Neoplasm, with or without demonstrable skeletal metastases ; as well as Iatrogenic,
due to acci dental parathormone overdosage or too vigorous pa.renteral repl acement
therapy in an attempt to treat hypocalcemia. In this review, the interesting finding
of hypercalcemia in the presence of malignant disease will be studied.

PHYSIOLOGY OF BLOOD CALCIUM
The average serum calcium values vary
from 9.5 to 10.5 mg. per 100 ml., thus
readings of 11 .0 mg. or above are considered to indicate a state of hypercalcemia.
The narrow limits of normal serum calcium are a result of numerous processes,
many as yet not understood, which contribute to physiological calcium homeostasis.
The following is a simplified resume of
blood calcium control. Calcium enters the
blood by three main routes; absorption
from the small intestine, resorption from
bone and by the parenteral route. Gastrointestinal absorption in turn depends on
specific factors; the pH of the intestine,
the nature and concentration of the anions
present, and the presence of Vitamin D .
Resorption from bone is in direct response
to the stimulus of parathormone which
activates the osteoclasts, promoting decalcification.
Calcium is removed from the blood by
excretion int o the large intestine, excretion into the urine and deposition in the
bones. The majority of fecal calcium is
actually the unabsorbed calcium taken in
the diet. The amount of calcium in the
urine ,average 150-180 mg. per 24 hours)
is affected directly by changes in renal
efficiency as well as indirectly by the
·150

action of parathormone.
In the blood, 40 of the calcium is combined with protein, chiefly albumin, thus,
indirectly, the blood protein concentration
determines the amount of calcium which
can be held in a non-diffusible form. The
remainder of the calcium consists of free
ions and is diffusible, along with a small
percentage which is combined with citrate.
Hypercalcemia occurs whenever this balance is upset in favor of more calcium
entering the blood stream than leaving it.

l

1

SIGNS AND SYMPTOMS
OF HYPERCALCEMIA
..
The clinical aspects of hypercalcemia are
well illustrated in the following case report, recorder by P. F. Lucas in the British
·
Medical Journal.•
A man, aged 49, had been perfectly well
until six weeks before admission to the
hospital. For three weeks, he was vaguely
unwell but able to work; he then became
increasingly drowsy, so that he would
sleep all day and, in the last week, complained of abdominal discomfort, constipation, polyuria, polydypsia, and vomiting
so severe that he could not keep even
fluids down in the previous 48 hours. He
had lost 24 pounds in this time.
The most striking clinical feature on
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admission was drowsiness, so marked that
he would drop off to sleep while talking . .
General examination was normal. The only
abnormal findings on special examination
were a serum calcium of 16 mg./100 ml.
and an inorganic phosphate of 2.2 mg./100
mi. X-ray examination showed chest, skull,
spine, pelvis and femurs to be normal .
A diagnosis of hyperparathryoidism was
made and the patient was put on a high
fluid intake. During the next ten days,
vomiting almost ceased and abdominal discomfort subsided. His drowsiness gradually
increased. The serum calcium rose steadily
to 18 mg./100 ml., the phosphate remaining below 3 mg./100 ml. The urine output
fell and the blood urea nitrogen rose to 90
mg./100 ml. Urina ry two calcium excretion
was 350 and 550 mg. in 24 hour periods.
On the eleventh day after admission, an
exploration of his neck was undertaken at
which a small swelling in the thyroid
proved to be a cyst; no other abnormality
was found .

Thus, in cases with a rapid onset, the
gastrointestinal symptoms include anorexia, nausea, vomiting and constipation
which result in weight loss. The central
nervous system symptoms include drowsiness, lethargy, confusion and disorientation which proceed to coma. Muscle weakness with hypotonia is often present. Renal
manifestations consist of polydypsia, polyuria, nocturia and a dry mouth. If 'these
are sustained for some time, deposits of
calcium occur within the renal tubules and
in the renal pelvis with eventual nephrocalcinosis and stone formation , leading to
mechanical impairment of kidney function
and eventual renal failure.
Myers found that the neurological features were predominant in this syndrome, 5
whereas Warwick et al found symptoms
referable to the gastrointestinal tract
appearing as 74% of the recorded
symptoms.1 0

TYPES OF MALIGNANCY

rl
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He remained unconscious for 36 hours
after operation and his condition appeared
terminal. The use of hydrocortisone caused
a decrease in his serum calcium t o 14
gm./100 ml. on the sixth post-operative day.
He improved .enough to be able to recognize his relatives, talk, and take fluids .
From the sixth to. ninth day, there was
considerable difficulty in mai ntaining electrolyte balance, and he became increasingly
drowsy, the blood urea nitrogen rising to
158 mg./100 ml. and the calcium to 16.2
mg./100 ml. He died nine days after
exploration in spite of continued cortisone
therapy. Sodium E.D.T.A. had no effect on
this terminal rise in calcium.
Autopsy showed widespread abdominal
carcinomatosis, with 't he primary, histologically an adeno: arcinoma, in the tail of t he
pancreas. There was also pancreatitis and
marked fat necrosis in the omentum. Macroscopic exami nation of several bones failed to show any metastases.
· NovEMBER,
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ASSOCIATED WITH
HYPERCALCEMIA

With Skeletal Metastases
Tumors which commonly involve bone
or the bone marrow, such as mammary,
bronchogenic or renal carcinomas, as well
as multiple myeloma and the lymphomatous diseases, have been the cause of hypercalcemia. Mammary carcinoma is the commonest malignancy associated with this
syndrome. Although thyroid and prostate
malignancies commonly metastasize to
bone, hypercalcemia is rarely a complicating feature. The growth of the tumor in
the osseous system causes its breakdown,
with a liberation of calcium into the blood
stream. This upsets the physiological balance and calcium is rapid ly excreted by the
kidneys until the maximum calcium load
is exceeded, then hypercalcemia becomes
evident. Thus, hypercalciuria always precedes hypercalcemia in the presence of
normal renal function .
151

-Hypercalcemia In Malignant Disease-----------Without Skeletal Metast3Ses
Much less frequently hypercalcemia has
been recorded in the presence of tumors in
which no clinical or radiological evidence
of osseous invasion was apparent, and
when post-mortem examination has shown
no secondaries in the bone.7 Such tumors
include a wide variety of malignancies, the
commonest one recorded being the hypernephroma of the kidney. 7 Others include
carcinoma of the G.I. tract, uterus, ovary,
testicle, and malignant lymphoma.
The cause is obscure but two mechanisms have been postulated to explain the
development of hypercalcemia in such
cases.
1. Some metabolic activity of the tumor

itself, which may cause bone resorption
without actually invading the skeleton.
2. The production by the tumor of a sub-

stance similar to parathormone whic:h is
injected into the blood stream, leading
to all the signs of hyperparathroidism.
Neither of these theories is supported
by direct evidence.

Recently, a few cases have been recorded
where normal serum phosphorous levels
were found in hyperparathyroid ism, 2 thus
this is not always a differentiating point.
Two additional tests, the tubular reabsorption of phosphorous, and the ten day
course of corticosteroid therapy have been
used to differentiate the causes of hypercalcemia. In some instances a parathyroid
exploration is resorted to in an effort to
confirm the diagnosis.
Another condition to be excluded is
central nervous system metastasis in known
cases of malignancy. The symptoms of
drowsiness, dizziness, dysarthria and confusion may lead to a strong suspicion of
brain metastasis, but there is an absence of
localizing neurological signs in hypercalcemia. These central nervous system symptoms have also been mistaken for psychoses, as a diagnosis of Alzheimer's Disease was made on a patient with hypernephroma and hypercalcemia. '
A careful history is often helpful in ruling out the other causes of hypercalcemia
listed in the introduction.

DIAGNOSIS
Since hypercalcemia can cause death fairly
rapidly, its diag nosis is essentiaL Every
physician should be suspicious if the above
symptoms appear, especially in a proven
case of malignancy, and serum calcium and
blood urea nitrogen studies should be
undertaken immediately. Serial laboratory
tests are essential, especially in gauging the
response of the patient to treatment.
The most important condition to be considered in the differential diagnosis is
hyperparathyroidism. The signs and symptoms may be identical but those associated
with hyperparthyroidism a.r e often more
insidious in their onset. It has been reported that in patients with neoplastic disease
and hypercalcemia, the serum calcium is
elevated and the serum phosphorous is
expected to be either normal or slightly
elevated, whereas in hyperparathyroidism
the serum phosphorous level is reduced.
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MANAGEMENT
A. Measures to reduce the serum calcium

I

j

1. Adequate hydration to promote cal-

cium output. This may require the
use of intravenous fluids if the patient is nauseated and vomiting.
B. Treatment of the underlying disease
(i.e. the neoplasm)
1. Medical:

a) Alteration of hormone environment by administration of estrogens, androgens or corticosteroids.
b) Chemotherapy, including nitrogen mustard and vi ncaleukoblastine.

··.1

2. Surgical :

a) Removal of the tumor if practical.
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b) Castration, adrenalectomy or
hypophysectomy, especially as
palliative measures in cases of
mammary carcinoma.
3. Radiotherapy:
a) Radiation to the tumor.
b) Radiation of localized osteolytic
metastases.
The use of sodium ethylenediamine
tetra-acetate (sodium EDTA) , a chelating
agent, which forms a soluble chelate with
calcium and enchances its renal excretion
has been disappointing.

toms related to this syndrome. The types
of malignancy associated with hypercalcemia, with and without bony metastases
include mammary, bronchogenic and renal
carcinomas, as well as multiple myeloma
and the lymphomas, mammary carcinomas
predominating. The differential diagnosis
is difficult in the case of primary hyperparathroidism. A resume of the management of hypercalcemia in malignancy includes immediate treatment of the hypercalcemia by restoration of proper fluid
balance and then appropriate treatment of
the underlying malig nancy.
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SUMMARY

I

The causes of hypercalcemia are listed
along with a short review of the blood
calcium physiology. Hypercalcemia in malignant· disease is illustrated with a case
report which points out the major symp-
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Student Research

...

Th e edi tors of th is journal feel th at unde rg rad u:!te medica l research is an inva lu able part
of today's scient ifically oriented phys ician, as
well ~ s an enjoyable experi ence with many
benefi ts. Many yea r after the frustrations of
word for word note-taking and the sweat before t·xams h:I.Ve been forgotten , the memori es
o f many hou rs spent aroun d the blackboa rd , the
appara tu s o r even the coffee table, sharing the
personal experience of a hig hly qu alified teacher
will be remembered. The invaluable trai ning of
research, invol ving hours of reading, exacti ng
ex perimentation, and finally the compilation
of :1 report and summary leaves the medical
student in a better position to take advantage
of th e cli n ical materia l which presents itself in
h i~ practice, and, th rough the medium of scientific journals, records his obesrvations and conclusions, to the material benefit of him elf and
his fellow physicia ns.
Th is year, we inaug urate a section o f the
J ou rn ~ l devo ted to student research .

THE OXYGEN PARADOX
Prior to the Second World War, certain
French and German aviators discovered a
paradoxical effect of oxygen. Following a
period of moderate hypoxia, precipitated by
any one of several reasons, the inhalation of
pure oxygen from their face masks often
brought on psychomotor disturbances such
as Joss of co-ordination , decreased powers
of discrimination , perception, and judgment, muscle cramps, and in severe cases,
momentary Joss of consciousness. Sporadic
reports in the research literature concern
human experiments and studies of psychomotor responses almost exclusively. Only
three investigations have been carried out
on animals to date.
In the series examined in the Department of Pharmacology this summer, cats
were chosen to study the effect of breathing of pure oxygen following a period of
increasing and severe hypoxia, upon the
heart rate, respiratory rate, blood pressure,
rectal temperature, and frontal and occipital cerebral cortical activity.
A decompression tank was employed to
raise the anesthetized animal to simulated
altitudes of 25,000 or 30,000 feet. Record-

154

1

1

ings of the above parameters were obtained from elect rical or thermocouple devices;
the Grass polygraph yielded tracings of all
parameters except rectal temperature in
which case a thermocouple was used.
In a pilot series of experiments, it was
found that if the blood pressure was allowed to fall by 30 to 50 per cent in a state of
increasing hypoxia, and the cat then was
made to breathe pure oxygen, maximum
effects were obtained. Later, comparisons
were made with animals allowed to continue to the end point in severe hypoxia.
Within twenty to forty seconds fo1Jowing
the intake of pure oxygen, the blood pressure fell precipitously, an extreme bradycardia arose, apnea set in, and electroencephalograms were depressed markedly.
In the cats allowed to continue in a state
of severe hypoxia, similar results were recorded, but only after a time interval three
to four times as long as the "oxygen"
animals. Rectal temperature changes were
not significant.
The mechanisms of action of the oxygen
paradox are likely one or several of the
following :
1. further severe cerebral ischemia due
to a relative passive cerebral blood
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pressure collapse when renewed peripheral circulation of oxygen causes
peripheral vasodilation.
2. oxygen poisoning of vital brain stem
centers, especially the respiratory
center.
3. reflex cerebral vasoconstriction upon
the administration of pure oxygen.
4. build up in the brain of toxic met-

abolic products such as lactic acid,
that cannot be removed when a passive decrease in cerebral blood pressure arises.

If oxygen is administered in concentrations somewhat less than 100 per cent, the
oxygen paradox will not arise. Also, a
hyperphysiological concentration of C0 2 ,
administered with a high 0 2 concentration
exerts a protective effect.
The clinical applications of these findings are obvious as far as aviation medicine
is concerned. It should also be pointed out
that oxygen paradox can arise in patients
suffering from severe and chronic obstructive pulmonary disease, if one treats a
hypoxic crisis by the administration of
pure oxygen.
This work was supervised and suggested
by Dr. C. W . Gowdey, professor of Pharmacology.
Loren Amacher, '62
Department of Pharmacology
Summer of 1961

INCORPORATION OF CYTIDINE
DIPHOSPHATE CHOLINE AND
SERINE IN PERIPHERAL NERVE
DURING WALLERIAN
DEGENERATION
It is well known that if a peripheral
nerve is cut, the portion of the nerve distal
to the point of section undergoes a series
of changes known as W allerian degene.raNOVEMBER.,

1961

tion. This is associated with a proliferation
of Schwann cells which are responsible for
the formation of the myelin sheath. The
following investigation was proposed to
study the labelling of the myelin phosphatides (i.e., the plasmalogens and sphingomyelin) , in comparison with the labelling in the phosphatides associated chiefly
with grey matter (i.e., lecithin and phosphatidyl serine) , using C14 labelled cytidine diphosphate choline and serine as
precursors.
The right sciatic nerve of rats was sectioned at the level of the greater trochanter
of the femur and allowed to degenerate.
After 4, 8, 16, or 32 days, the animals
were sacrificed and the sciatic nerves were
removed, the left nerve being used as a
control. The nerves were homogenized and
incubated in a buffered medium with
known amounts of cytidine diphosphate
choline-C'• and serine-C14 . The lipids were
extracted, purified and divided into an
alkali-stable fraction (the myelin lipids)
and an alkali-labile fraction (mainly grey
matter lipids) .
In control nerves and during the first
32 days of Wallerian degeneration, no significant amounts of cytidine diphosphate
choline or serine were incorporated into
the alkali-stable plasmalogen-sphingomyelin fraction. However, both compounds
were incorporated readily into the alkalilabile glycerophosphatide fraction . Lecithin and phosphatidyl serine in the latter
fraction showed a steady increase in labelling as the nerves degenerated . Phosphatidyl serine was labelled more rapidly
reaching a peak at 16 days degeneration.
The results will be interpreted in the
light of previous studies and studies now
in progress in the Department of Biochemistry.

Keith Fidler, '62
Department of Biochemistry
Summer of 1961.
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Historical
Dr. Walter Bapty, Meds '06, reminisces
on some of the early teachers and p rocedures around the Medical School.

NOTES ON SOME TEACHERS
AT THE MEDICAL SCHOOL
My first introduction to medicine commenced with a lecture in Anatomy, delivered by Dr. Hadley Williams, a man with
a brilliant mind, dedicated to his work.
Physically, he was not a large man, but he
did command respect with his piercing
eyes, a black moustache, and a clear penetrating voice. Because he was a rapid and
fluent speaker, he kept order in class,
which was made up of " unruly" students
of 1905-06, as both years received the
same lecture.
Hadley was a great anatomist, and he
knew his subject thoroughly, having received his F.R.C.S. in England. It was said
that shortly after his arrival there, and
without any coaching, he had taken his
primary and passed in anatomy. When lecturing, he showed artistic talent, for he
illustrated his subject on the blackboard
by using colored chalk. He bad the un usual ability of drawing with both hands,
when picturing symmetrical parts, such as
cross sections of the brain, cord or chest.
Much of our anatomy was taught in the
classroom, with the help of Gray's textbook. Afternoons were spent in dissection
and our teacher was our demonstrator. The
details of Dr. Williams's lectures have been
forgotten, but he did impress upon us the
importance of Embryology, and its bearing
on many hereditary malformations. Our
class had only one term of Anatomy with
Dr. Williams, for the following year, he
became an Associate Professor of Surgery.
Dr. Ed Seaborn -followed ~as Chief in the
Anatomy Departinent. Very different in

appearance, lacking the fire and brilliance
of his predecessor, Dr. Seaborn created
rather a feeling of assurance and faith in
our chosen profession. It must be remembered that for the most part, our teachers
were general practitioners. However, the
period of specialization was beginning. Dr.
Hugh McCallum was devoting himself to
Internal Medicine. He persuaded Dr. John
MacGregor of Nebraska, to assist him and
to teach pathology at Western. Doctors
John Wishart and Hadley Williams were
surgeons; Doctors Meek and Eccles confined themselves to Obstetrics. I have only
a dim memory of Dr. Williams as a clinical teacher. Some years later, when visiting
Victoria Hospital, I observed him performing an operation, without a mask. Its
absence was not unusual among older surgeons, and even at that date, a few senior
men did not wear rubber g loves when
operating.
Names of many professors have eluded
me, but I do recall Doctors Jim Campbell,
and Nev for Physiology. It was not until
my third year that I was aware of the
dynamic personality of Dr. Hugh McCallum. Imposing in appearance, as he was
over six feet in height, thick-set, and overweight, he was full of life and good
natured humor. Due to his enthusiasm and
inspiration, Medicine was a favorite subject. His instruction was chiefly clinical,
and "Osler" was his t ext. He often quoted
Osler's sayiug that pneumonia was "the
captain of the men of Death" . Though he
was in the prime of life another remark
I remember was, "If pneumonia strikes me,
it will be the end." That was prophetic far
he succumbed to it not long after.
· Dr. Walter Moorhouse, a professor of
Medidne,·· .was -also· oo . the .staff: H e ·was
pas:t his pr~e :.and . had lost all : ~t;. _·Too
dignified· a- bearing; coupled -with ·ascetic
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face, did not appeal to the students, so his
classes usually ended in an uproar. A quiet
voice and a ready wit endeared Dr. Wishart to all. Dr. John MacGregor was just
commencing his duties as pathologist at
Victoria Hospital, and instructor at the
school. He was such a keen student himself, that he inspired all who came in
contact with him .
Shortly after, we graduated-and we did
graduate! Our class of 1906 was so lacking
in discipline that we were given a private,
hush-hush convocation in the old University Building by Huron College where we,
in all sincerity, took the Hippocratic Oath.
The Flexner Report on Medical Education was publ ished within a short time.
Many of the findings were true, especially

the lack of laboratories and other facilities.
What that report could not discover was
the consecration of a body of medical men
who devoted their time and money towards
the training of students in the concepts of
good and honest medical practice. Such
was my loyalty to Western University that
when I discovered a copy of the Flexner
report in the office of a high government
official, I confiscated it and later destroyed
it. Though this report did not give credit
where credit was due, it had its part in
leading to a higher and better standard
of medical training throughout Canada
and the United States.
Walter Bapty, M.D. '06.
April 27, 1961, Oshawa.

News And Views
Western University was honored to have
Dr. Otto Saphir present the sixteenth
annual John A. MacGregor Memorial Lecture on September 27, 1961. Dr. Saphir,
distinguished pathologist from Michael
Reese Hospital in Chicago, spoke on
"Pyelonephritis Leota and its Role in the
Etiology of Mal ig nant Hypertension."
The lecturer stressed that Pyelonephritis
Leota is an asymptomatic, insidious cause
of malignant hypertension, and showed
how it caused proliferation of the renal
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arteriolar intima without producing an
inflammatory reaction in the surrounding
interstitial tissue. He went on to explain
that the subcapsular petichial hemorrhages,
seen in this syndrome, were due to the
uremia inherent to the terminal stages.
Dr. Fisher, head of the U.W.O. department of Pathology, presided over the lecture and closed the meeting by drawing
attention to the keeness of the observations
of Dr. Saphir which led to this hypothesis.
George De Young, '63
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Book Review
Management of Hypertensive Diseases
by Joseph C. Edwards, 439 pages, ECG
and x-ray plates, C. V. Mosby Co., St.
Louis. 15.00.
This review is written in late 1961 and
at least some of the criticism is based upon
rapid developments in this field of medical
therapeutics since the date of publication.
Leonardo Da Vinci comments that "those
who abridge works do injury to knowledge . . ."
The painfully slow progress of therapeutics is based upon the careful observation of disease throughout its natural
history and notation and reflection upon
modifications which can be induced in its
course. As such, a large portion of this
book, relating to therapeutic experience
under varying circumstances and complications, is interesting and instructive reading.
Impressive is the meticulous care in dosage
adjustment and its flexibility and the importance of paient's intelligent cooperation. The author is a polypharmacist, frequently using three drugs simultaneously
to achieve a "smoothing out" of irregular
blood pressure response.
Progress in the field now suggests combination of thiazide with blocking or sympathicolytic agent. The discussion of
guanethidine seems to disregard the significance of its long-delayed hypotensive
effect, rendering the implied relation of
the momentary blood pressure as a guide
to the next dose of the drug, dangerous
and misleading.

but so condensed as to be of little value
to the reader. The section dealing with the
controversy surrounding the " renal" basis
for essential hypertension, adds nothing to
the clarity of the controversy itself, nor
does it seem relevant to the avowed purpose of this volume.
Allowing this criticism, this book represents a milestone in the clinical reporting
of hypertension. Here is gathered, not in
vague generality, but in specific detail, the
author's method of treatment of individual
patients. Various stages and complications
are represented. The results of this treatment are clearly portrayed with helpful
diagramatic clarification. Relief of symptoms, altering physical and laboratory signs
are shown for individual patients. How
much more meaningful this approach may
seem to the physician than is the stifling
quotation of statistics applying to "significant numbers", while individual tragedy
or comforting success is buried in the
"mean".
That the careful, conscientious medical
therapist has contributed to the comfort
and longevity of the more severe hypertensive, is clearly portrayed. That further
advance-of significant comfort to the
patient, has occurred since publication of
this work, is cause for further optimism.
The paper is shiny, the glare annoying.
The printing is clear and the reproductions
faultless.

Less common causes of hypertension are
dealt with in a clear and helpful way.
Technical detail of some of the more complex diagnostic procedures are closely
outlined.

This book cannot now be recommended
by this reviewer as an authorative source
book on the current therapeutics in hypertension, but it can be read with profit by
those wishing the case report method of
presentation, cataloguing the modification
of hypertension by effective treatment.

Discussion of cardiac dynamics and
theories of pathogenesis are broad in scope,

Sept. 22, 1961

158

]. A. Lewis, M.D.

1

1

Abstracts
USE OF TOTAL-BODY RADIATION

IN THE TREATMENT OF FAR
ADVANCED MALIGNANOES
King, E. R., JAMA, 177: 610-613, 1961.
For several decades, attempts have been
made to use total-body radiation as a form
of cancer therapy. Originally, there were
attempts made with low-energy x-rays,
radium, and, later, with the internally administered radio-nuclides P 32 , Na2 \ K 42 ,
Au198 , etc. Within the past 15 years, the
production of the long half-life radionuclides, Co60 and Cs 131 , each with energetic
gamma-ray emissions, has made available
adequate and economical radiation sources
for the delivery of nearly uniform doses to
the human. In addition, interest has been
generated regarding the uses of total-body
radiation in the problem of the immunologic response and the homotransplantation of organs.
With this introduction, the author described a two year study with cobalt-60
irradiation. Exposure methods and dosimetry were discussed in some detail. Then,
patients treated with a single dose of
total-body radiation were compared with
patients who were treated with multiple
doses .
In all, 17 patients with far advanced
cancer were treated with total-body radiation. Good palliative responses were
achieved in 6 patients treated with small
repeated doses. The results of 11 patients
treated with a single dose varied. All patients
were followed from the standpoint of
gastrointestinal symptoms, cardiovascular
symptoms, bacterial infections, and hematology studies. Additional studies were
done on the urinary excretions of aminoacids. The clinical findings reportedly
associated with acute radiation exposure

were not significant in these latter 11
patients.
Robert Moffat, '62

MALIGNANT MELANOMA
James, A. G., JAMA, 176: 5-7, 1961.
This author analysed 130 cases of malignant melanoma over a 10 year period. His
patients ranged from 13-91 years in age,
and no cases were observed before puberty.
A definite history of pre-existing mole at
the site of melanoma was obtained in 63
patients.
Treatment consisted of a type of surgical
excision:
a) if the primary lesion was in close
proximity to a regional node-bearing area,
this area was radically resected whether or
not there was demonstrable metastatic
disease.
b) if the primary lesion was distantly
removed from the nearest nodal area and
this area contained no clinical evidence of
disease, then only wide excision was done.
c) if the primary lesion was in an ex~
tremity with nodes involved, an amputation was done.
No form of radiation was considered.
Absolute survival rates were:
42% for 3 years,
32% for 5 years,
19% for 10 years.
The author felt that these end-result
figures were not consistent with the teaching that melanoma is the most lethal
malignancy in man.
Robert Moffat, '62
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CHANGES IN BRONCHIAL
EPITHELIUM IN RELATION TO
CIGARETTE SMOKING AND
IN RELATION TO LUNG CANCER
A. P. Stout, New Eng. J. of Med ., 265: 6,
p. 253, 1961.
In an attempt to correlate cigarette
smoking and lung cancer, the authors dissected the tracheo-bronchial tree from the
lungs of 402 male, white patients dying
with and without lung cancer. Each specimen was then divided into 208 sections,
and, from among these sections, 55 sites
were selected for microscopic study in each
case. These were coded to eliminate bias,
and each studied for the presence of three
pathological findings : loss of cilia from the
epithelial cells, increase in the number of
rows of cells, atypism of cells. The observations were then recorded and statistically
analysed in relation to smoking habits.
It was found that each of the three variables increased rapidly with the amount of
cigarette smoking, both in the number of sections showing the change, and in the degree
of change. These changes were of somewhat
the same magnitude in persons smoking
heavily as in those who had died of lung
cancer. In sections from non-smokers such
lesions that were found showed, more
often than not, only one of the above listed
changes. In sections from heavy smokers
and those who had died of carcinoma of
the lung, atypical cells were found in every
lesion that showed hyperplasia and loss of
cilia. This does not, however, mean that in
all cases the lesion would have become
invasive if the patient had not died of
some other disease.

Robert F. Southern, '62
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CARCINOMA OF THE BREAST
R. J. Utzschneider, J. C. McCann Jr., New
Eng. J. of Med., 263:871 , 1960.
The report evaluates 245 new cases of
carcinoma of the breast in a New England
Hospital. Patients ranged in ages from 27
years to 91 years, the average being 57.6
years. 18.3 % were between 70 and 79 years
of age. The average length of time between
the appearance of first symptoms or signs
and hospitalization was 31 weeks, ranging
from 1 day to 7 years. 16.3% revealed a
history of cancer in blood relations.
55% of all tumors were found on the
left and 45 % were found on the right, the
majority being found in the upper, outer
quadrant. 72% were t reated with radical
mastectomy, 11 % with simple mastectomy
and 17% were considered inoperable. Of
the 72 % undergoing radical mastectomy,
38% had histologic proof of involvement of
the axillary lymph nodes, 62% having no
involvement in this area.

In the follow-up of 100% of the original 245 cases, ·the five-year survival of all
cases treated with radical mastectomy (i.e.
176 cases) , regardless of node metastases,
was found to be 69 0 , and ten year survival was 45 %. Of those who had no axillary
metastases, 75 .2% survived for five years,
and of those with axi llary metastases,
47.8 %. Of the inoperable cases, only 7%
survived five years and of those with
simple mastectomy, 25 % .
Robert F. Southern, '62

ACCESSORY ADRENOCORTICAL
FUNCTION AFTER ADRENALECTOMY IN PATIENTS WITH BREAST
CANCER
Sim. A. W ., Hobkirk, R., Blai r, D . W .,
Stewart, H ., Lancet, 2: 73-76, 1961.
It is a well-known fact that bilateral
adrenalectomy and oophorectomy may in -

...
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-
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.

duce remarkable improvement m the
course of metastatic breast cancer in
women. However, sooner or later, ren ewed
growth and multiplication of tumor cells
lead to relapse and death.
Why? Did the endocrine surgery deprive
the malignancy of some essential factor for
active growth, and the eventual relapse
come about from the development of an
accessory source of adreno-ovarian hormones?
With this question in mind, the investigators studied 6 patients whose metastatic
breast cancer had regressed after surgery,
in order to try to detect any residual
adreno-cortical function. Generally, the
tests comprised serial estimations of adrenal hormones and their metabolites in the
urine and peripheral blood before, during,
and after a post-operative period when
cortisone therapy was stopped.
Their findings, in patients whose cancer
had relapsed, were identical with those
in patients whose tumor had regressed, and
they indicated that relapse of cancer is not
associated with the development of functioning adreno-cortical tissue. Also, no
adrenal rests were demonstrated at 2 postmortems.

Robert Moffat, '62

CARCINOMA AND CUSHING'S
SYNDROME
Billinghurst, J. R., Thould, A. K ., Galpin,
0 . P., Hinton, J. M ., BMJ, 490-493, 1961.
In this article, the authors present 2
cases in which carcinoma of the bronchus
was associated with Cushing's Syndrome.
There are presently 43 cases of non-adrenal
malig nancy in the literature associated
with Cushing's Syndrome. A point of interest is that there was no significant
alkalosis in these 2 cases as in most of the
others, but there was a definite hypokalemia.
As in previous cases, obesity, gain in
weight, hypertension, thirst, polyuria, and
hirsutism were all noted as clinical findings. Interestingly enough, the development of the syndrome was very rapid in
all reported cases. Also, there was a high
female incidence (19 of 43) . The authors
discussed several theories as to why the
syndrome might be associated with a malignancy but none were entirely satisfactory.
Finally, they stressed the need to be
aware of such an association, partly to
avoid the erroneous diagnosis that the
primary neoplasm lies in the adrenal
cortex, and partly to prevent the patient's
undergoing a fruitless adrenalectomy when
a primary neoplasm elsewhere is unsuspected.
Robert Moffat, '62
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ARREST OF PREMA1URE LABOR

Bishop, E. H . and Wootersz, T.B., J.A.
M.A. 178: 212, 1961.
Premature labor occurs in about 10%
of all pregnancies and is the most frequent
complication during the last half of pregnancy. It is also well known that premature labor poses a great threat to the
welfare of the fetus.
In this study, the authors attempted to
demonstrate the effect of a myometrial
relaxant, inoxsuprine hydrochloride on the
human uterus in premature labor. The
study consisted of 156 patients in premature labor. Before treatment, several
criteria had to be fulfilled :
1. Pregnancy between 20 and 36 weeks.

2. Evidence of premature labor such as
dilatation of the cervix, bloody show,
or abnormal uterine contractions.
3. Cervix less than 4 em. dilated.
4. Intact membranes.
5. Absence of any complications contraindicating the continuation of pregnancy.

..

I

r
...

When the drug was administered, it
was found to have no effect on labor in
25 % of all cases. In 11.5% of cases labor
was interrupted for only a short period of
time. In a third group labor was delayed
for one week or longer in 21.2 % of patients but the fetus at delivery weighed
less than 2500 grams. Finally in 42.3% of
patients, labor ceased after inoxsuprine administration and did not recur until the
infant reached a birth weight of at least
2500 grams. Results were even better in
a more sdected group.
In 66% of patients, it was found that
premature uterine contractions ceased for
a significant period of time with inoxsuprine therapy.
Robert Moffat, '62
JANUARY,
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TRACHEOTOMYITS COMPLICATIONS
AND THEIR MANAGEMENI'
Meade,
1961.

J. W ., New

Eng.

J. Med. 265 :519,

It has often been said that tracheotomy,
one of the oldest operations in surgery, is
one of the most frequently done improperly, and most often mismanaged in the
after-care.
The author once again brings this to
our attention by presenting a series of 212
tracheotomies and their complications.
The complication rate was 33 % and the
mortality 2.8% .
The complications were discussed under
operative and post-operative headings.
Operative complications consisted of emphysema (subcutaneous and mediastinal),
pneumothorax and low incisions. Postoperative complications were much more
numerous. Pneumonia was noted in 11
cases and resulted in 2 deaths. In 6 patients atdectasis secondary to obstruction
from mucous plugs developed. Other postoperative complications were endotracheitis cannula difficulties, hemorrhage,
sepsis, and carbon dioxide retention.
It was also mentioned that meticulous
post-operative care was most essential.. ~f
the tracheal air was not kept well humtdtfied and the inner cannula frequently
cleaned, then obstruction by mucous plugs
and viscid secretions was bound to occur.
It was felt that most complications were
preventable and could be avoided by careful operative technic and good postoperative management.
Robert Moffat, '62
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